These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 27428416)

  • 1. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer.
    Zhao R; Choi BY; Lee MH; Bode AM; Dong Z
    EBioMedicine; 2016 Jun; 8():30-39. PubMed ID: 27428416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Tumor Suppressor Gene CDKN2A and Encoded p16-INK4a Protein by Covalent Modifications.
    Jiao Y; Feng Y; Wang X
    Biochemistry (Mosc); 2018 Nov; 83(11):1289-1298. PubMed ID: 30482142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments.
    Witkiewicz AK; Knudsen KE; Dicker AP; Knudsen ES
    Cell Cycle; 2011 Aug; 10(15):2497-503. PubMed ID: 21775818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis.
    Zhang Y; Tong T
    Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular balancing act of p16(INK4a) in cancer and aging.
    LaPak KM; Burd CE
    Mol Cancer Res; 2014 Feb; 12(2):167-83. PubMed ID: 24136988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
    Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP; Burns KL; Rosenberg AE; Louis DN
    Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
    van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.
    Kato S; Schwaederle M; Daniels GA; Piccioni D; Kesari S; Bazhenova L; Shimabukuro K; Parker BA; Fanta P; Kurzrock R
    Cell Cycle; 2015; 14(8):1252-9. PubMed ID: 25695927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
    Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
    Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
    Becker TM; Rizos H; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Oct; 7(10):3282-8. PubMed ID: 11595726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells.
    Yao JY; Zhang L; Zhang X; He ZY; Ma Y; Hui LJ; Wang X; Hu YP
    J Biol Chem; 2010 Jun; 285(24):18828-37. PubMed ID: 20382980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication.
    Zannetti C; Mondini M; De Andrea M; Caposio P; Hara E; Peters G; Gribaudo G; Gariglio M; Landolfo S
    Virology; 2006 May; 349(1):79-86. PubMed ID: 16504234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.
    Villuendas R; Sánchez-Beato M; Martínez JC; Saez AI; Martinez-Delgado B; García JF; Mateo MS; Sanchez-Verde L; Benítez J; Martínez P; Piris MA
    Am J Pathol; 1998 Sep; 153(3):887-97. PubMed ID: 9736037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors.
    Romagosa C; Simonetti S; López-Vicente L; Mazo A; Lleonart ME; Castellvi J; Ramon y Cajal S
    Oncogene; 2011 May; 30(18):2087-97. PubMed ID: 21297668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.